MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 181 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $823 | -99.9% | 24,795 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $778,000 | +3.5% | 24,673 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $752,000 | +19.7% | 24,743 | +2.3% | 0.00% | +50.0% |
| Q1 2022 | $628,000 | +144.4% | 24,180 | +92.2% | 0.00% | +100.0% |
| Q4 2021 | $257,000 | -5.9% | 12,583 | -11.3% | 0.00% | 0.0% |
| Q3 2021 | $273,000 | -16.3% | 14,190 | -3.4% | 0.00% | -50.0% |
| Q2 2021 | $326,000 | -13.1% | 14,691 | +2.9% | 0.00% | -33.3% |
| Q1 2021 | $375,000 | +33.0% | 14,278 | -5.4% | 0.00% | +50.0% |
| Q4 2020 | $282,000 | +29.4% | 15,095 | +17.3% | 0.00% | 0.0% |
| Q3 2020 | $218,000 | -27.3% | 12,864 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $300,000 | -49.2% | 12,864 | -62.2% | 0.00% | -72.7% |
| Q4 2018 | $591,000 | +57.2% | 34,051 | +54.8% | 0.01% | -35.3% |
| Q3 2015 | $376,000 | +5.6% | 22,000 | +15.0% | 0.02% | 0.0% |
| Q2 2015 | $356,000 | – | 19,125 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |